Top Stories
GSK, iTeos to develop cancer drug in up to $2 billion deal
Published by Wanda Rich
Posted on June 14, 2021
· Last updated: January 21, 2026
Related Articles
The Silent Shift Reshaping Global Finance
The Invisible Forces Rewiring Global Finance—And Why the Shift Is Already Underway
The Global Finance Reset No One Is Talking About—But Everyone Is Feeling
The Financial Trend Hiding in Plain Sight—Why Everything Feels the Same, But Isn’t
The Financial System’s New Rhythm—Why Change Is Happening Without Disruption
More from Top Stories
Explore more articles in the Top Stories category
The Subtle Forces Reshaping Global Finance—And Why They Matter Now
The Quiet Realignment of Global Finance—Why the System Is Changing Without a Shock
The Global Financial Shift That Feels Small—But Is Changing Everything
The Financial System’s Invisible Pivot—Why the Biggest Changes Don’t Make Headlines
Why Global Supply Chains Are Becoming Smarter, Faster, and More Resilient
Why Workforce Agility Is Becoming Critical in the Future of Work
Why Global Trade Is Entering a New Era of Resilience and Reinvention
Why Cybersecurity Is Becoming a Core Business Priority in the Digital Economy
Why Data-Driven Decision-Making Is Becoming the Backbone of Modern Business Strategy
How Real-Time Data Is Redefining Decision-Making in the Digital Economy
Why Cash Flow Visibility Is Becoming the Most Critical Metric for Business Survival
How Digital Payments Are Redefining the Speed and Scale of Global Commerce